January 31, 2024
Are Device Technology Personnel Valid or Valued Assets?
Cian Tan, Mohammed Idhrees, Mohamad Bashir, et al.
July 28, 2022
Aortic valve neocuspidization using autologous versus bovine pericardium: Ozaki versu...
Matti Jubouri, Sven Zhen Cian Tan, Mohammed Idhrees, et al.
March 15, 2022
Is Open Thoracoabdominal Aortic Aneurysm Repair Following Frozen Elephant Trunk Justi...
Mohamad Bashir, Sven Zhen Cian Tan, Matti Jubouri, et al.
January 07, 2022
Criteria for Endovascular Intervention in Type B Aortic Dissection
Sven Zhen Cian Tan, Sidhant Singh, Joaquin Alfonso Palanca, et al.
December 21, 2021
Reply to Jubouri and Abdelhaliem
Sven Zhen Cian Tan and Mohamad Bashir
November 12, 2021
External or subcomissural annuloplasty in bicuspid aortic valve repair: which is bett...
Metesh Acharya, Hiwa Sherzad, Sven Zhen Cian Tan, et al.
October 22, 2021
Prevention vs. Cure: is BioGlue priming the optimal strategy against E-Vita Neo graft...
Cian Tan and Mohamad Bashir
September 25, 2021
Correlation of Coagulopathy and Frozen Elephant Trunk Use in Aortic Arch Surgery: A S...
Mohamad Bashir, Hadi Abo Aljadayel, Mostafa Mousavizadeh, et al.
September 25, 2021
Uniformity in bioprosthetic mitral valve sizing -- when will we get there?
Cian Tan, Mohamad Bashir, Mohammed Idhrees, et al.
September 25, 2021
Are Aortic Surgery Device Technology Providers Valid or Valued Assets?
Cian Tan, Mohammed Idhrees, Mohamad Bashir, et al.
July 07, 2021
Hybrid, Endovascular, or Open Approach -- the Paget Schroetter Syndrome Dilemma
Mohamad Bashir, Cian Tan, M Ghali Salahia, et al.
May 25, 2021
Aortic Proximalisation -- Zone 0 vs. Zone 2. A Concept or True Challenge?
Cian Tan, Aleksandra Lopuszko, Wahaj Munir, et al.